Literature DB >> 14006532

A clinical study of 5-fluorouracil in a variety of far advanced human malignancies.

J E WHITE, W N RICKETTS, W J STRUDWICK.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; URACIL/related compounds

Mesh:

Substances:

Year:  1962        PMID: 14006532      PMCID: PMC2642282     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  5 in total

1.  Clinical applications of the fluorinated pyrimidines.

Authors:  R R ELLISON
Journal:  Med Clin North Am       Date:  1961-05       Impact factor: 5.456

2.  Use of 5-fluorouracil in treatment of bladder carcinomas.

Authors:  T L DEREN; W L WILSON
Journal:  J Urol       Date:  1960-04       Impact factor: 7.450

3.  The comparative utilization of uracil-2-C14 by liver, intestinal mucosa, and Flexner-Jobling carcinoma in the rat.

Authors:  C HEIDELBERGER; K C LEIBMAN; E HARBERS; P M BHARGAVA
Journal:  Cancer Res       Date:  1957-06       Impact factor: 12.701

4.  Introduction of unnatural pyrimidines into deoxyribonucleic acid of Escherichia coli.

Authors:  S ZAMENHOF; B REINER; R DE GIOVANNI; K RICH
Journal:  J Biol Chem       Date:  1956-03       Impact factor: 5.157

5.  Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma.

Authors:  R J RUTMAN; A CANTAROW; K E PASCHKIS
Journal:  Cancer Res       Date:  1954-02       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.